Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.

Background: In this study, we evaluated the ability of radiomic textural analysis of intratumoral and peritumoral regions on pretreatment breast cancer dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to predict pathological complete response (pCR) to neoadjuvant chemotherapy (NAC).Met...

Full description

Bibliographic Details
Published in:Breast Cancer Research Vol. 19; pp. 1 - 15
Main Authors: Braman, Nathaniel M., Etesami, Maryam, Prasanna, Prateek, Dubchuk, Christina, Gilmore, Hannah, Tiwari, Pallavi, Pletcha, Donna, Madabhushi, Anant, Plecha, Donna
Format: pictorial research tables/charts Journal Article
Published: BioMed Central 5/18/2017
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=123155838&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 123155838
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14655411
        8UYJ
      jtl: Breast Cancer Research
      issn: 14655411
      maglogo: N
    pubinfo:
      dt: 5/18/2017
      vid: 19
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        123155838
        123155838
        NLM28521821
        123155838
        10.1186/s13058-017-0846-1
        NLM28521821
        123155838
      ppf: 1
      ppct: 14
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
      aug:
        au:
          Braman, Nathaniel M.
          Etesami, Maryam
          Prasanna, Prateek
          Dubchuk, Christina
          Gilmore, Hannah
          Tiwari, Pallavi
          Pletcha, Donna
          Madabhushi, Anant
          Plecha, Donna
        affil: Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106, USA
      sug:
        subj:
          Receptors, Cell Surface
          Magnetic Resonance Imaging Methods
          Breast Neoplasms
          Contrast Media Administration and Dosage
          Female
          Breast Neoplasms Pathology
          Neoadjuvant Therapy
          Adult
          Breast Pathology
          Antineoplastic Agents, Combined Administration and Dosage
          Breast Neoplasms Drug Therapy
          Middle Age
          Human
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Female
      ab: Background: In this study, we evaluated the ability of radiomic textural analysis of intratumoral and peritumoral regions on pretreatment breast cancer dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to predict pathological complete response (pCR) to neoadjuvant chemotherapy (NAC).Methods: A total of 117 patients who had received NAC were retrospectively analyzed. Within the intratumoral and peritumoral regions of T1-weighted contrast-enhanced MRI scans, a total of 99 radiomic textural features were computed at multiple phases. Feature selection was used to identify a set of top pCR-associated features from within a training set (n = 78), which were then used to train multiple machine learning classifiers to predict the likelihood of pCR for a given patient. Classifiers were then independently tested on 39 patients. Experiments were repeated separately among hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+, HER2-) and triple-negative or HER2+ (TN/HER2+) tumors via threefold cross-validation to determine whether receptor status-specific analysis could improve classification performance.Results: Among all patients, a combined intratumoral and peritumoral radiomic feature set yielded a maximum AUC of 0.78 ± 0.030 within the training set and 0.74 within the independent testing set using a diagonal linear discriminant analysis (DLDA) classifier. Receptor status-specific feature discovery and classification enabled improved prediction of pCR, yielding maximum AUCs of 0.83 ± 0.025 within the HR+, HER2- group using DLDA and 0.93 ± 0.018 within the TN/HER2+ group using a naive Bayes classifier. In HR+, HER2- breast cancers, non-pCR was characterized by elevated peritumoral heterogeneity during initial contrast enhancement. However, TN/HER2+ tumors were best characterized by a speckled enhancement pattern within the peritumoral region of nonresponders. Radiomic features were found to strongly predict pCR independent of choice of classifier, suggesting their robustness as response predictors.Conclusions: Through a combined intratumoral and peritumoral radiomics approach, we could successfully predict pCR to NAC from pretreatment breast DCE-MRI, both with and without a priori knowledge of receptor status. Further, our findings suggest that the radiomic features most predictive of response vary across different receptor subtypes.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N